Daunorubicin hydrochloride and cytarabine liposome

From WikiMD.org
Jump to navigation Jump to search
Daunorubicin hydrochloride and cytarabine liposome
TermDaunorubicin hydrochloride and cytarabine liposome
Short definitionDaunorubicin hydrochloride and cytarabine liposome - (pronounced) (DAW-noh-ROO-bih-sin HY-droh-KLOR-ide …sy-TAYR-uh-been LY-poh-some) form of the cancer drugs daunorubicin hydrochloride and cytarabine contained in very small, fat-like particles, used to treat adults with certain types of newly diagnosed acute myeloid leukemia. Daunorubicin hydrochloride and cytarabine liposomes may have fewer side effects and work better than other forms of these drugs. 
TypeCancer terms
SpecialtyOncology
LanguageEnglish
SourceNCI
Comments


Daunorubicin hydrochloride and cytarabine liposome - (pronounced) (DAW-noh-ROO-bih-sin HY-droh-KLOR-ide …sy-TAYR-uh-been LY-poh-some) form of the cancer drugs daunorubicin hydrochloride and cytarabine contained in very small, fat-like particles, used to treat adults with certain types of newly diagnosed acute myeloid leukemia. Daunorubicin hydrochloride and cytarabine liposomes may have fewer side effects and work better than other forms of these drugs. It is also being studied in the treatment of other types of cancer. Daunorubicin hydrochloride and cytarabine liposomes are a type of anthracycline antibiotic, a type of topoisomerase inhibitor and a type of antimetabolite. Also called Vyxeos

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski